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(A) Without the presence of 
rGO-nafion (B) Presence of 
rGO-nafion. Both undergo 
the complete immobilization 
process. 
 
Abstract 
 
Hepatitis B (Hep B) is a viral infection caused by hepatitis B virus (HBV) that infects the 
human liver. HBV is blood-borne and transfusion-transmitted human pathogen that has a 
large impact on blood safety and public health worldwide. Approximately 5% of the 
Malaysian population is infected by HBV. The treatment to this disease is possible if early 
detection is done before irreversible liver damage occurs. The presence of hepatitis B 
virus surface antigen (HBsAg) is an evidence of the presence of HBV infections. Presently, 
the conventional methods used for detection show weaknesses in terms of time and 
efficiency. In this research, the functionality of reduced graphene oxide (rGO) as an 
immuno biosensor for the detection of HBsAg has been studied. The graphene oxide was 
prepared via Modified Hummer’s Method due to its ability to produce graphene in large 
quantity. The fabrication of immunosensor was conducted by immobilizing antibody onto 
the graphene. nafion-graphene nanosheet was grown and later treated with thionine 
solution. Following that, a solution of primary antibodies against Hep B surface antigen 
(anti-HBsAg IgG) was incubated on the biosensor. After the immobilization, the antigen 
was dropped onto the biosensor, followed by incubation of secondary antibodies 
conjugated to Horseradish Peroxidase (HRP). Upon addition of Tetramethylbenzidine 
(TMB), the colour of the solution changes to blue. Thus, proving the functionality of rGO as 
an immunobiosensor for the detection of HBsAg. 
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Abstrak 
 
Hepatitis B (Hep B) adalah jangkitan virus yang disebabkan oleh virus hepatitis B (HBV) 
yang menjangkiti hati manusia. HBV berjangkit melalui transfusi darah dan ini mempunyai 
kesan yang besar pada keselamatan darah dan kesihatan awam di seluruh dunia. Kira-
kira 5% daripada penduduk Malaysia dijangkiti HBV dan rawatan terbaik adalah untuk 
pengesanan awal sebelum kerosakan hati berlaku. Kewujudan antigen permukaan 
Hepatitis B (HBsAg) adalah bukti kehadiran jangkitan HBV. Pada masa ini, kaedah 
konvensional yang digunakan untuk pengesanan menunjukkan kelemahan dari segi 
masa dan kecekapan. Dalam kajian ini, kami berhasrat untuk mengkaji tentang 
kemungkinan ‘reduced graphene okside’ (rGO) sebagai bahan asas untuk biosensor 
imun untuk mengesan HBsAg. rGO disediakan melalui Kaedah Modified Hummer kerana 
kemampuannya untuk menghasilkan graphene dalam kuantiti yang besar. Fabrikasi 
immunosensor telah dijalankan dengan memperkenalkan antibodi kepada graphene. 
nafion-graphene serpihan dirawat dengan larutan Thionine. Berikutan itu, satu larutan 
antibodi utama Hep B antigen (anti-HBsAg IgG) telah dieram pada biosensor terdahulu. 
Selepas itu, antigen yang digugurkan ke biosensor, diikuti oleh pengeraman antibodi 
sekunder konjugasi dengan ‘Horseradish Peroxidase’ (HRP). Berikutan dengan 
penambahan Tetramethylbenzidine (TMB), warna larutan akan berubah kepada biru. 
Sebagai kesimpulan, rGO boleh digunakan sebagai bahan asas untuk biosensor. 
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1.0  INTRODUCTION 
 
Hep B is a disease caused by HBV that attacks the 
liver. A HBV infection can cause both acute and 
chronic diseases,1which is a major health problem 
occurring in all parts of the world.2 The World Health 
Organisation,3 mentioned that approximately 780 000 
people die each year due to the acute or chronic 
consequences of Hep B. In Malaysia, 5% of its 
population is affected by Hep B.4 Hence, the best 
treatment for Hep B is to eliminate the virus before the 
occurrence of irreversible liver damage. For this to be 
successful, accurate detection of HBV infections in the 
early stages is crucial. The conventional methods of 
detecting HBV such as ELISA and PCR is time 
consuming,5 hence, it is essential to identify low cost, 
rapid, high selectivity and sensitivity bio-diagnosis 
markers present at ultra-low level during early stages of 
infections. Therefore, the research on graphene based 
biosensor for the purpose of early detection of HBV is 
crucial in terms of cost and effectiveness.  
Graphene is much favored for the usage as a 
biosensor due to its unique physicochemical properties 
such as high surface area and extraordinary electron 
transfer ability,6 which are useful for the purpose of a 
biosensor. Previous studies have proven that further 
reduction of graphene oxide improved the properties 
exhibited by graphene.7-9 The presence of a large 
number of oxygen-containing functional groups and 
structural defects10 enhanced rGO’s chemical activity 
compared to graphene. 
AIM: To study on the functionality of rGO as as 
immuno-biosensor for the detection of HBsAg. 
 
 
2.0  EXPERIMENTAL 
 
2.1  Material 
 
Nafion 117 solution and thionine acetate salt were 
obtained from Sigma Aldrich. The hepatitis B virus 
surface antigen (HBsAg) was purchased from MP 
Biomedicals Asia Pacific Pte. Ltd. with the product 
name Purified human HBsAg subtype ad (Article No. 
COMM-9002). The primary antibody Hepatitis B surface 
antigen antibody (HRP) (Cat. No. GTX19990), 
secondary antibody, Hepatitis B surface antigen 
antibody [HB6] (HRP) (Cat. No. GTX40106) and  
 
 
 
 
tetramethylbenzidine (TMB) were purchased from 
Gene Tex. 
 
2.2  Experimental Procedures 
 
2.2.1 Synthesis of Reduced Graphene Oxide (rGO) 
 
The rGO was prepared by using Modified Hummer’s 
Method.11-13 The prepared rGO was kept in a vacuum 
desiccator until used. Characterization of rGO was 
conducted by means of Ultraviolet- Visible (UV-Vis) 
Spectrometer and Fourier Transform Infrared 
Spectroscopy (FTIR). UV-Vis was conducted to observe 
the reaction process of the production of rGO, 14 
whereas FTIR characterization was conducted to 
determine the functional groups present in rGO.15 
 
2.2.2 Functionalization of Reduced Graphene Oxide 
(rGO) 
 
The rGO was used to grow the rGO-nafion nanosheet 
by ultrasonication in 0.25% nafion-water for 30-50 
minutes to obtain a homogenous, well distributed 
suspension of rGO-nafion composite. The prepared 
rGO-nafion solutions were stored at room temperature 
until time of use. 
 
2.2.3 Immobilization of Hepatitis B Surface Antigen 
(HBsAg) 
 
100 uL of rGO-nafion was added onto a treated 
surface and allowed to dry to fabricate the biosensor. 
Next, thionine solution (3mM) was added onto the 
surface and allowed to soak for 10 minutes. The 
treated biosensor surface is then incubated with 
primary antibody (100 μL) at 37°C for half an hour. The 
antibody was then removed and the sample was 
washed (5X) with 1X PBS (250 μL/well), approximately1 
minute per wash. The non-specific binding of the 
primary antibody is the blocked with 1% BSA/PBS (200 
μL/well) and incubated further for an hour at 37°C. The 
fabricated biosensor was sealed and frozen at -70°C 
until use.  
Figure 1 shows the methodology developed for the 
detection of HBsAg using the rGO biosensor. The 
antigen was introduced onto the sensor and 
incubated for half an hour at room temperature and 
followed by a similar washing process (5X) with1X PBS.  
The sensor was then incubated with the secondary 
antibody (conjugated with HRP) for 30 minutes at room 
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(A)
 
 
(B)
 
 
temperature and followed by washing (5X) with 1X 
PBS. Next, TMB (100 μL/well) was incubated for 15 
minutes. TMB is a chromogenic substance used in the 
staining procedures of immunohistochemistry as well 
as a visualizing reagent for enzyme-linked 
immunosorbent assays (ELISA) and reading was taken 
at 450 nm.16 The immobilization of HBsAg was 
replicated three times. 
 
Figure 1 Methodology for detection of HBsAG using the RGO 
biosensor 
 
 
3.0  RESULTS AND DISCUSSION 
 
3.1  Characterization 
 
The yellowish brown liquid (Figure 2(A)) shows the 
dispersion of graphene oxide (GO) in water before 
reduction. This viscous solution contained graphite 
oxide and exfoliated sheets as well as non-oxidized 
graphitic particles and residues of the oxidizing agents 
from the reaction mixture.15 The black solution in Figure 
2(B) represents the rGO. The rGO formed was then 
filtered and washed profusely with water and finally 
with acetone. The rGO precipitation (powder) 
obtained was later be functionalized with 0.5% nafion 
as seen in Figure 2(C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Dispersion of (A) graphene oxide (B) reduced 
graphene oxide) (C) reduced graphene oxide – 0.5% nafion 
 
The characterization of the produced rGO was 
conducted via UV-Vis spectroscopy and FTIR. In Figure 
3, the UV-Vis absorption spectra of rGO before and 
after undergoing reduction are shown. The absorption 
peak shifted from 230 nm to 265 nm14,17. The shift in 
peak is due to the electronic conjugation within the 
reduced graphene sheets upon the reduction of 
graphene oxide in the presence of hydrazine.14,17 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Graph of absorbance vs. wavelength obtained from 
UV-Vis Spectroscopy shows the peak shift from 231nm to 
265nm 
 
 
Figure 4 shows the FTIR spectra of graphite and rGO. 
Graphite spectra produced insignificant peaks while 
rGO spectra showed the presence of different 
functional groups Among them are hydroxyl (O-H) 
group at 3236.03 cm-1, alkane (C-H) group at 2959.82 
cm-1 and 2917.50 cm-1, carboxyl (R-C(O)OH) group at 
1698.58 cm-1. Carboxyl group is still present in which it is 
suggested that the aqueous solution of rGO is still 
charged even after reduction. 14 
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Figure 4 FTIR spectra of (A) graphite and (B) reduced graphene oxide 
(rGO) 
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3.2 Immobilization of Hepatitis B Surface Antigen 
(HBsAg) 
 
The binding of HBsAg with antibody was confirmed 
with the introduction of TMB substrate at room 
temperature for 15 minutes. As shown in Figure 5, TMB 
substrates detected HRP activity, thus yielding a blue 
color solution.  
 
Figure 5 (A) Without the presence of rGO-nafion (B) Presence 
of rGO-nafion. Both undergo the complete immobilization 
process 
 
 
To summarize, the developed immobilization process 
required approximately 1 hour and 25 minutes in order 
for the Hep B antigen to be detected. From the results 
obtained it shows that rGO could be a potential matrix 
as an immunosensor. However, further study is advised 
to further confirm the functionality of rGO as an 
immune biosensor. Electrochemical characterization 
of the functionalized rGO as an immunosensor can be 
developed for better understanding on the 
biocompatibility of rGO.  
 
 
4.0  CONCLUSION 
 
The development of an rGO based immunoassay for 
the detection of HBsAg is feasible as shown in the 
results obtained. The colour-change obtained from 
visual observation has proven the functionality of rGO 
as an immune-biosensor. This is probably due to the 
unique characteristics, 11 of having high surface area 
and also the presence of active sites which are used 
for the binding of antibody which will attach the 
respective antigen.  
From the results obtained, without the presence of 
rGO, anti-HBsAg IgG is unable to bind to the surface as 
there is no rGO present. Hence, with the presence of 
rGO functionalized with the anti-HBsAg IgG is able to 
attach the HBsAg. TMB is a colourless substance which 
only changes color in the presence of HRP contained 
in the secondary antibody. 
However, it is recommended that further study is 
required to have better understanding on the 
functionalized rGO as an immunosensor.  
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